Pharmacodynamic Therapeutic Drug Monitoring for Cancer: Challenges, Advances, and Future Opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacodynamic Therapeutic Drug Monitoring for Cancer: Challenges, Advances, and Future Opportunities

Published:2019-04 Issue:2 Volume:41 Page:142-159
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Veal Gareth J.,Amankwatia Edward B.,Paludetto Marie-Noëlle,Möcklinghoff Till,Thomson Fiona,André Nicolas,Ciccolini Joseph,Chatelut Etienne

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference199 articles.

1. Therapeutic drug monitoring in cancer—are we missing a trick?;Bardin;Eur J Cancer.,2014

2. Preclinical mouse solid tumour models: status quo, challenges and perspectives;Gengenbacher;Nat Rev Cancer.,2017

3. Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers;Adjei;J Clin Oncol.,2008

4. Cytokeratin markers come of age;Linder;Tumour Biol.,2007

5. A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera;Biven;Apoptosis.,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update;Journal of Chromatography B;2024-04

2. Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review;Therapeutic Advances in Medical Oncology;2024-01

3. Peripheral blood mononuclear cell derived biomarker detection using eXplainable Artificial Intelligence (XAI) provides better diagnosis of breast cancer;Computational Biology and Chemistry;2023-06

4. Simultaneous quantification of pirarubicin, doxorubicin, cyclophosphamide, and vincristine in human plasma of patients with non-Hodgkin's lymphoma by LC–MS/MS method;Journal of Chromatography B;2023-05

5. Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital;Acta Oncologica;2023-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3